logo Go to homepage Holoclara Holoclara
  • Overview Overview
  • Governance Governance
  • Press Press
  • Contact
Home/Press Releases

OurBlog Posts

We purged worms from our bodies — and may have made ourselves sick

September 4, 2025

Dr. Andrea Choe, MD, Ph.D. – CEO, Holoclara – Worm-Derived Therapeutics For Debilitating Diseases

August 26, 2025

Parasites as Medicine? Dr. Andrea Choe on Immunomodulation & Autoimmune Disease | Ep. 16

January 27, 2025

Holoclara’s announcement entering Phase 1 clinical trials and targeting Eosinophilic esophagitis is featured in Fierce Biotech.

December 18, 2024

Holoclara’s first-in-class technology detailed in Forbes’ The Prototype.

September 20, 2024

Holoclara Announces Head of Research and Development Hire

August 9, 2024

Worm-Derived Therapeutics For Debilitating Diseases

July 23, 2024

Holoclara’s Series A Financing featured in exclusive Fortune coverage.

June 27, 2024

Holoclara announces $16M Series A Financing to advance a breakthrough class of worm-derived therapeutics for allergic and autoimmune disease.

June 27, 2024

Taking on Autoimmune Diseases—with Worms!

June 21, 2024

1 2 Next »

Holoclara

info@holoclara.com info@holoclara.com
X X Linkedin Linkedin
 

Newsletter

Stay in the know with our newsletter
covering the latest industry news and insights.

    © Holoclara